AdaptHealth Corp.

Historical 13F Holders

Symbol
AHCO
CUSIP
00653Q102
All holders as of
Q2 2026
Type
Equity
Class
COMMON STOCK
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00653Q102 since 12/18/2024, newest first.

Filer % of Class Filed
Reinhart Partners, LLC. 13G/A Amendment 1 0% 10/13/2026
Event 3/31/2025
Dimensional Fund Advisors LP 13G/A Amendment 1 4.7% 10/8/2026
Event 9/30/2026
Dimensional Fund Advisors LP 13G 5.1% 4/9/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 5 0% 3/26/2026
Event 3/13/2026
Cashin Richard M Jr 13D/A Amendment 4
11.7% 3/12/2026
Event 3/10/2026
FMR LLC 13G/A Amendment 1
5.6% 2/5/2026
Event 12/31/2025
James E. Flynn 13G/A Amendment 5
8.5% 11/13/2025
Event 9/30/2025
Vanguard Group Inc 13G/A Amendment 4 8.3% 10/30/2025
Event 9/30/2025
FMR LLC 13G
6.7% 8/6/2025
Event 6/30/2025
BlackRock, Inc. 13G/A Amendment 4 10.9% 7/17/2025
Event 6/30/2025
Reinhart Partners, LLC. 13G 5.4% 5/15/2025
Event 3/31/2025
FMR LLC 13G/A Amendment 2
5.0%
Checked 5% or less
5/12/2025
Event 3/31/2025
Pacer Advisors, Inc. 13G/A Amendment 1
0% 5/2/2025
Event 3/31/2025
Pacer Advisors, Inc. 13G
6.0% 5/2/2025
Event 12/31/2024
Jefferies Financial Group Inc. 13G/A Amendment 1
3.8% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 14 634 k $3.62 M
2026 Q2 252 142 M $1.57 B
2026 Q1 251 141 M $1.68 B
2025 Q4 249 139 M $1.39 B
2025 Q3 243 137 M $1.23 B
2025 Q2 238 139 M $1.31 B
2025 Q1 248 133 M $1.44 B
2024 Q4 225 131 M $1.24 B
2024 Q3 237 124 M $1.39 B
2024 Q2 222 117 M $1.17 B
2024 Q1 226 117 M $1.34 B
2023 Q4 204 114 M $834 M
2023 Q3 206 114 M $1.03 B
2023 Q2 192 108 M $1.32 B
2023 Q1 186 112 M $1.38 B
2022 Q4 210 109 M $2.09 B
2022 Q3 202 103 M $1.94 B
2022 Q2 161 93.2 M $1.68 B
2022 Q1 161 95.0 M $1.52 B
2021 Q4 166 88.3 M $2.15 B
2021 Q3 151 72.2 M $1.68 B
2021 Q2 148 68.7 M $1.88 B
2021 Q1 158 65.2 M $2.40 B
2020 Q4 142 43.2 M $1.10 B
2020 Q3 82 25.5 M $557 M
2020 Q2 56 10.3 M $166 M
2020 Q1 37 24.4 M $390 M
2019 Q4 25 22.6 M $248 M
2019 Q3 2 1.25 M $12.7 M